Narrator: This is Science Today. The translation of basic research for public benefit is a priority at the University of California, San Francisco.
Lium: We want to be able to take our findings, whether they're inventions in the area of drugs, devices, diagnostics or now, what is becoming increasingly active is the area of digital health; we want to make sure that our ideas and our inventions and our findings are ultimately translated for public benefit.
Narrator: Erik Lium, who leads the campus' Office of Innovation, Technology and Alliances, is also involved in a National Science Foundation-funded partnership called I-Corps, which aims to help commercialize university innovations.
Lium: The purpose of these programs is really to help individuals that have these ideas, have made nascent inventions to translate them into a company and ultimately bring them to the marketplace, commercialize them.
Narrator: For Science Today, I'm Larissa Branin.